B. Krebs

The Membrane Proximal Cytokine Receptor Domain of the Human Interleukin-6 Receptor Is Sufficient for Ligand Binding but Not for gp130 Association*

S. Rose-John, A. Wollmer, J. Grötzinger, 1998, The Journal of Biological Chemistry.

Specific targeting of cytokine-secreting cells: a bispecific diabody recognizing human interleukin-6 and CD3 induces T cell-mediated killing.

S. Rose-John, B. Ackermann, B. Krebs, 1998, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Methodical Studies in the Separation of Chlorophyll-Protein Complexes by Polyacrylamide Gel Electrophoresis

A. Wild, W. Rühle, B. Krebs, 1980 .

Antifibrotic effects of a tissue inhibitor of metalloproteinase‐1 antibody on established liver fibrosis in rats

Christopher J. Parsons, Barbara Krebs, D. Brenner, 2004, Hepatology.

Recombinant Human Single Chain Fv Antibodies Recognizing Human Interleukin-6

S. Rose-John, G. Winter, B. Krebs, 1998, The Journal of Biological Chemistry.

High-throughput generation and engineering of recombinant human antibodies.

Manqiu Cao, M. Tesar, R. Schier, 2001, Journal of immunological methods.

Activation signals in human lymphocytes: interleukin 2 synthesis and expression of high affinity interleukin 2 receptors require differential signalling for the activation of protein kinase C.

M. Kracht, K. Resch, U. Hübner, 1990, Cellular immunology.

Activation signals in human lymphocytes. Incorporation of polyunsaturated fatty acids into plasma membrane phospholipids regulates IL-2 synthesis via sustained activation of protein kinase C.

K. Resch, B. Rehermann, M. Szamel, 1989, Journal of immunology.

Generation and optimization of human antagonistic antibodies against TIMP-1 as potential therapeutic agents in fibrotic diseases.

C. Pan, B. Brocks, S. Zahn, 2007, Human antibodies.